These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2420642)

  • 1. Antiviral activity of a chemically stabilized 2-5A analog upon microinjection into HeLa cells.
    Defilippi P; Huez G; Verhaegen-Lawalle M; De Clercq E; Imai J; Torrence P; Content J
    FEBS Lett; 1986 Mar; 198(2):326-32. PubMed ID: 2420642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity towards VSV and Mengo virus of a chemically stabilized 2-5A analog upon microinjection into HeLa cells.
    Defilippi P; Huez G; Verhaegen-Lewalle M; De Clercq E; Torrence P; Content J
    Prog Clin Biol Res; 1985; 202():141-6. PubMed ID: 3008170
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies on (2'-5')oligoadenylate-related enzyme systems and the antiviral effect of interferon in two mouse cell lines which differ in (2'-5')oligoadenylate sensitivity of their protein synthesizing system.
    Taira H; Yamamoto F; Furusawa M; Sawai H; Kawakita M
    J Interferon Res; 1985; 5(4):583-96. PubMed ID: 2418128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogue inhibitor of 2-5A action: effect on the interferon-mediated inhibition of encephalomyocarditis virus replication.
    Watling D; Serafinowska HT; Reese CB; Kerr IM
    EMBO J; 1985 Feb; 4(2):431-6. PubMed ID: 2410258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells.
    Silverman RH; Skehel JJ; James TC; Wreschner DH; Kerr IM
    J Virol; 1983 Jun; 46(3):1051-5. PubMed ID: 6190010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of interferon action III--significance of pppA2'p5'A2'p5'A in the antiviral action of interferon.
    Liu XY; Yao K; Zhou YX; Jin JR; Wen YM; Lou YC; Li BL; Wang DB
    Sci Sin B; 1983 Aug; 26(8):809-17. PubMed ID: 6194560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microinjection of interferon and 2',5'-oligoadenylate into mouse L cells and their effects on virus growth.
    Higashi Y; Sokawa Y
    J Biochem; 1982 Jun; 91(6):2021-8. PubMed ID: 6181054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-mediated antiviral state in human MRC5 cells in the absence of detectable levels of 2-5A synthetase and protein kinase.
    Meurs E; Hovanessian AG; Montagnier L
    J Interferon Res; 1981 Feb; 1(2):219-32. PubMed ID: 6180053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 2'5'-oligoadenylic acid on a mouse cell line partially resistant to interferon.
    Panet A; Czarniecki CW; Falk H; Friedman RM
    Virology; 1981 Oct; 114(2):567-72. PubMed ID: 6170160
    [No Abstract]   [Full Text] [Related]  

  • 10. Xyloadenosine analogue of (A2'p)2A inhibits replication of herpes simplex viruses 1 and 2.
    Eppstein DA; Barnett JW; Marsh YV; Gosselin G; Imbach JL
    Nature; 1983 Apr; 302(5910):723-4. PubMed ID: 6300696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase.
    Cayley PJ; Davies JA; McCullagh KG; Kerr IM
    Eur J Biochem; 1984 Aug; 143(1):165-74. PubMed ID: 6088228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.
    Rice AP; Roberts WK; Kerr IM
    J Virol; 1984 Apr; 50(1):220-8. PubMed ID: 6422053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral effects of 2',5'oligoadenylates (2-5As), and related compounds.
    Tominaga A; Saito S; Kohno S; Sakurai K; Hayakawa Y; Noyori R
    Microbiol Immunol; 1990; 34(9):737-47. PubMed ID: 2178211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon action--sequence specificity of the ppp(A2'p)nA-dependent ribonuclease.
    Wreschner DH; McCauley JW; Skehel JJ; Kerr IM
    Nature; 1981 Jan; 289(5796):414-7. PubMed ID: 6162102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analogs of (A2'p)nA. Correlation of structure of analogs of ppp(A2'p)2A and (A2'p)2A with stability and biological activity.
    Eppstein DA; March YV; Schryver BB; Larsen MA; Barnett JW; Verheyden JP; Prisbe EJ
    J Biol Chem; 1982 Nov; 257(22):13390-7. PubMed ID: 7142154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of the ppp(a2'p)nA system in HeLa cells. Effects of interferon and virus infection.
    Silverman RH; Cayley PJ; Knight M; Gilbert CS; Kerr IM
    Eur J Biochem; 1982 May; 124(1):131-8. PubMed ID: 6177533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'5' Oligoadenylate analogues:synthesis, biological activities and intracellular delivery.
    Bisbal C; Bayard B; Silhol M; Leserman L; Lebleu B
    Prog Clin Biol Res; 1985; 202():89-95. PubMed ID: 3008175
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A.
    Baglioni C; Minks MA; Maroney PA
    Nature; 1978 Jun; 273(5664):684-7. PubMed ID: 208001
    [No Abstract]   [Full Text] [Related]  

  • 19. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells.
    Wreschner DH; James TC; Silverman RH; Kerr IM
    Nucleic Acids Res; 1981 Apr; 9(7):1571-81. PubMed ID: 6164990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B).
    Homan JW; Steele AD; Martinand-Mari C; Rogers TJ; Henderson EE; Charubala R; Pfleiderer W; Reichenbach NL; Suhadolnik RJ
    J Acquir Immune Defic Syndr; 2002 May; 30(1):9-20. PubMed ID: 12048358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.